An investigation on behalf of investors in Eli Lilly and Company (NYSE: LLY) shares over potential wrongdoing at Eli Lilly and Company was announced.
San Diego, CA -- (SBWIRE) -- 11/17/2020 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Eli Lilly and Company.
Investors who purchased shares of Eli Lilly and Company (NYSE: LLY) a have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Eli Lilly and Company (NYSE: LLY officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
In August 2020, Eli Lilly and Company began a clinical trial to test whether adding the Company's antibody-based drug, LY-CoV555, to remdesivir would benefit patients diagnosed with COVID-19.
On October 13, 2020, the trial's sponsor, the National Institute of Allergy and Infectious Diseases ("NIAID") recommended that the trial be paused after an analysis of safety data found "an overall difference in clinical status between the group receiving LY-CoV555 and the group receiving saline placebo."
Those who purchased shares of Eli Lilly and Company (NYSE: LLY) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.